Palliative treatment of germ cell cancer
•For the first time a definition of palliative is provided for germ-cell cancer patients. To our knowledge, this has never been attempted before.•We give a comprehensive review on treatment options.•We provide a clear algorithm for choosing palliative treatments.•We give expert advise on how to appr...
Gespeichert in:
| Veröffentlicht in: | Cancer treatment reviews 2018-12, Vol.71, p.102-107 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 107 |
|---|---|
| container_issue | |
| container_start_page | 102 |
| container_title | Cancer treatment reviews |
| container_volume | 71 |
| creator | Oing, Christoph Giannatempo, Patrizia Honecker, Friedemann Oechsle, Karin Bokemeyer, Carsten Beyer, Jörg |
| description | •For the first time a definition of palliative is provided for germ-cell cancer patients. To our knowledge, this has never been attempted before.•We give a comprehensive review on treatment options.•We provide a clear algorithm for choosing palliative treatments.•We give expert advise on how to approach a patient before being declared palliative.
Most patients with metastatic germ-cell cancer (GCC) can be cured by cisplatin-based combination chemotherapy. Yet, about 10–15% of metastatic GCC patients will eventually die of their disease. This narrative review focuses on treatment options when cure is no longer realistic. |
| doi_str_mv | 10.1016/j.ctrv.2018.10.007 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2132248829</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0305737218301695</els_id><sourcerecordid>2132248829</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-ee91aa5c17c396935bf25e552b8c6b5f321a8918a15618ad9b82fb1b49b78b4c3</originalsourceid><addsrcrecordid>eNp9kEtLAzEUhYMotlb_gAuZZTdT85hkEnAjxRcUdKHrkGTuSMpMpyZpwX9vhlaXbu6FwzmHez-ErgleEEzE7XrhUtgvKCYyCwuM6xM0JZzRkihRn6IpZpiXNavpBF3EuMYYKybUOZowXBFOsJii-ZvpOm-S30ORApjUwyYVQ1t8QugLB11XOLNxEC7RWWu6CFfHPUMfjw_vy-dy9fr0srxfla6iIpUAihjDHakdU0IxblvKgXNqpROWt4wSIxWRhnCRZ6OspK0ltlK2lrZybIbmh95tGL52EJPufRzvMBsYdlFTwiitpKQqW-nB6sIQY4BWb4PvTfjWBOuRkF7rkZAeCY1aJpRDN8f-ne2h-Yv8IsmGu4MB8pd7D0FH5yEjaHwAl3Qz-P_6fwBg93XH</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2132248829</pqid></control><display><type>article</type><title>Palliative treatment of germ cell cancer</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Oing, Christoph ; Giannatempo, Patrizia ; Honecker, Friedemann ; Oechsle, Karin ; Bokemeyer, Carsten ; Beyer, Jörg</creator><creatorcontrib>Oing, Christoph ; Giannatempo, Patrizia ; Honecker, Friedemann ; Oechsle, Karin ; Bokemeyer, Carsten ; Beyer, Jörg</creatorcontrib><description>•For the first time a definition of palliative is provided for germ-cell cancer patients. To our knowledge, this has never been attempted before.•We give a comprehensive review on treatment options.•We provide a clear algorithm for choosing palliative treatments.•We give expert advise on how to approach a patient before being declared palliative.
Most patients with metastatic germ-cell cancer (GCC) can be cured by cisplatin-based combination chemotherapy. Yet, about 10–15% of metastatic GCC patients will eventually die of their disease. This narrative review focuses on treatment options when cure is no longer realistic.</description><identifier>ISSN: 0305-7372</identifier><identifier>EISSN: 1532-1967</identifier><identifier>DOI: 10.1016/j.ctrv.2018.10.007</identifier><identifier>PMID: 30415106</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Antineoplastic Agents - therapeutic use ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Bone Neoplasms - secondary ; Bone Neoplasms - therapy ; Brain Neoplasms - secondary ; Brain Neoplasms - therapy ; Drug therapy ; Germ cell cancer ; Germ cell tumor ; Humans ; Immunotherapy - methods ; Molecular Targeted Therapy - methods ; Neoplasms, Germ Cell and Embryonal - pathology ; Neoplasms, Germ Cell and Embryonal - therapy ; Palliative Care - methods ; Palliative treatment ; Peripheral Nervous System Diseases - etiology ; Platinum-refractory ; Psychosocial Support Systems</subject><ispartof>Cancer treatment reviews, 2018-12, Vol.71, p.102-107</ispartof><rights>2018 The Authors</rights><rights>Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c426t-ee91aa5c17c396935bf25e552b8c6b5f321a8918a15618ad9b82fb1b49b78b4c3</citedby><cites>FETCH-LOGICAL-c426t-ee91aa5c17c396935bf25e552b8c6b5f321a8918a15618ad9b82fb1b49b78b4c3</cites><orcidid>0000-0001-5578-3418 ; 0000-0003-1755-9700</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ctrv.2018.10.007$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30415106$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oing, Christoph</creatorcontrib><creatorcontrib>Giannatempo, Patrizia</creatorcontrib><creatorcontrib>Honecker, Friedemann</creatorcontrib><creatorcontrib>Oechsle, Karin</creatorcontrib><creatorcontrib>Bokemeyer, Carsten</creatorcontrib><creatorcontrib>Beyer, Jörg</creatorcontrib><title>Palliative treatment of germ cell cancer</title><title>Cancer treatment reviews</title><addtitle>Cancer Treat Rev</addtitle><description>•For the first time a definition of palliative is provided for germ-cell cancer patients. To our knowledge, this has never been attempted before.•We give a comprehensive review on treatment options.•We provide a clear algorithm for choosing palliative treatments.•We give expert advise on how to approach a patient before being declared palliative.
Most patients with metastatic germ-cell cancer (GCC) can be cured by cisplatin-based combination chemotherapy. Yet, about 10–15% of metastatic GCC patients will eventually die of their disease. This narrative review focuses on treatment options when cure is no longer realistic.</description><subject>Antineoplastic Agents - therapeutic use</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Bone Neoplasms - secondary</subject><subject>Bone Neoplasms - therapy</subject><subject>Brain Neoplasms - secondary</subject><subject>Brain Neoplasms - therapy</subject><subject>Drug therapy</subject><subject>Germ cell cancer</subject><subject>Germ cell tumor</subject><subject>Humans</subject><subject>Immunotherapy - methods</subject><subject>Molecular Targeted Therapy - methods</subject><subject>Neoplasms, Germ Cell and Embryonal - pathology</subject><subject>Neoplasms, Germ Cell and Embryonal - therapy</subject><subject>Palliative Care - methods</subject><subject>Palliative treatment</subject><subject>Peripheral Nervous System Diseases - etiology</subject><subject>Platinum-refractory</subject><subject>Psychosocial Support Systems</subject><issn>0305-7372</issn><issn>1532-1967</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtLAzEUhYMotlb_gAuZZTdT85hkEnAjxRcUdKHrkGTuSMpMpyZpwX9vhlaXbu6FwzmHez-ErgleEEzE7XrhUtgvKCYyCwuM6xM0JZzRkihRn6IpZpiXNavpBF3EuMYYKybUOZowXBFOsJii-ZvpOm-S30ORApjUwyYVQ1t8QugLB11XOLNxEC7RWWu6CFfHPUMfjw_vy-dy9fr0srxfla6iIpUAihjDHakdU0IxblvKgXNqpROWt4wSIxWRhnCRZ6OspK0ltlK2lrZybIbmh95tGL52EJPufRzvMBsYdlFTwiitpKQqW-nB6sIQY4BWb4PvTfjWBOuRkF7rkZAeCY1aJpRDN8f-ne2h-Yv8IsmGu4MB8pd7D0FH5yEjaHwAl3Qz-P_6fwBg93XH</recordid><startdate>20181201</startdate><enddate>20181201</enddate><creator>Oing, Christoph</creator><creator>Giannatempo, Patrizia</creator><creator>Honecker, Friedemann</creator><creator>Oechsle, Karin</creator><creator>Bokemeyer, Carsten</creator><creator>Beyer, Jörg</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5578-3418</orcidid><orcidid>https://orcid.org/0000-0003-1755-9700</orcidid></search><sort><creationdate>20181201</creationdate><title>Palliative treatment of germ cell cancer</title><author>Oing, Christoph ; Giannatempo, Patrizia ; Honecker, Friedemann ; Oechsle, Karin ; Bokemeyer, Carsten ; Beyer, Jörg</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-ee91aa5c17c396935bf25e552b8c6b5f321a8918a15618ad9b82fb1b49b78b4c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Antineoplastic Agents - therapeutic use</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Bone Neoplasms - secondary</topic><topic>Bone Neoplasms - therapy</topic><topic>Brain Neoplasms - secondary</topic><topic>Brain Neoplasms - therapy</topic><topic>Drug therapy</topic><topic>Germ cell cancer</topic><topic>Germ cell tumor</topic><topic>Humans</topic><topic>Immunotherapy - methods</topic><topic>Molecular Targeted Therapy - methods</topic><topic>Neoplasms, Germ Cell and Embryonal - pathology</topic><topic>Neoplasms, Germ Cell and Embryonal - therapy</topic><topic>Palliative Care - methods</topic><topic>Palliative treatment</topic><topic>Peripheral Nervous System Diseases - etiology</topic><topic>Platinum-refractory</topic><topic>Psychosocial Support Systems</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oing, Christoph</creatorcontrib><creatorcontrib>Giannatempo, Patrizia</creatorcontrib><creatorcontrib>Honecker, Friedemann</creatorcontrib><creatorcontrib>Oechsle, Karin</creatorcontrib><creatorcontrib>Bokemeyer, Carsten</creatorcontrib><creatorcontrib>Beyer, Jörg</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer treatment reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oing, Christoph</au><au>Giannatempo, Patrizia</au><au>Honecker, Friedemann</au><au>Oechsle, Karin</au><au>Bokemeyer, Carsten</au><au>Beyer, Jörg</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Palliative treatment of germ cell cancer</atitle><jtitle>Cancer treatment reviews</jtitle><addtitle>Cancer Treat Rev</addtitle><date>2018-12-01</date><risdate>2018</risdate><volume>71</volume><spage>102</spage><epage>107</epage><pages>102-107</pages><issn>0305-7372</issn><eissn>1532-1967</eissn><abstract>•For the first time a definition of palliative is provided for germ-cell cancer patients. To our knowledge, this has never been attempted before.•We give a comprehensive review on treatment options.•We provide a clear algorithm for choosing palliative treatments.•We give expert advise on how to approach a patient before being declared palliative.
Most patients with metastatic germ-cell cancer (GCC) can be cured by cisplatin-based combination chemotherapy. Yet, about 10–15% of metastatic GCC patients will eventually die of their disease. This narrative review focuses on treatment options when cure is no longer realistic.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>30415106</pmid><doi>10.1016/j.ctrv.2018.10.007</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-5578-3418</orcidid><orcidid>https://orcid.org/0000-0003-1755-9700</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0305-7372 |
| ispartof | Cancer treatment reviews, 2018-12, Vol.71, p.102-107 |
| issn | 0305-7372 1532-1967 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2132248829 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Antineoplastic Agents - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bone Neoplasms - secondary Bone Neoplasms - therapy Brain Neoplasms - secondary Brain Neoplasms - therapy Drug therapy Germ cell cancer Germ cell tumor Humans Immunotherapy - methods Molecular Targeted Therapy - methods Neoplasms, Germ Cell and Embryonal - pathology Neoplasms, Germ Cell and Embryonal - therapy Palliative Care - methods Palliative treatment Peripheral Nervous System Diseases - etiology Platinum-refractory Psychosocial Support Systems |
| title | Palliative treatment of germ cell cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T18%3A21%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Palliative%20treatment%20of%20germ%20cell%20cancer&rft.jtitle=Cancer%20treatment%20reviews&rft.au=Oing,%20Christoph&rft.date=2018-12-01&rft.volume=71&rft.spage=102&rft.epage=107&rft.pages=102-107&rft.issn=0305-7372&rft.eissn=1532-1967&rft_id=info:doi/10.1016/j.ctrv.2018.10.007&rft_dat=%3Cproquest_cross%3E2132248829%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2132248829&rft_id=info:pmid/30415106&rft_els_id=S0305737218301695&rfr_iscdi=true |